• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

You know it's bad when we leave for Sotyktu

anonymous

Guest
Just finished S2 meeting. Thoughts?

First, the Real World Evidence was a nothing burger. Detail aid sucks hard.
Second, I talked to 6 long term reps and they all are interviewing with UCB, Regeneron, Galderma and Leo.
Third, what shocked me the most (not really given how we are treated) was that at least 3 are interviewing with BMY to sell SoJAKtoo.

If that happens, then hell has frozen over.

Not a one of them said they even did validation this time. No one cares since IC is a mystery and we don't even get Birdi or Owl.
 

<



Similar threads

Replies
185
Views
38K
Amgen
anonymous
Replies
29
Views
5K
Amgen
anonymous
Replies
24
Views
6K
Amgen
anonymous
Replies
7
Views
3K
Amgen
anonymous